tci Medicare Compliance & Reimbursement - 2003 Issue 8

Reimbursement: GAO TARGETS NEW AWP PAYMENT HEMORRHAGE

As with most covered drugs and biologicals,Medicare pays way too much for blood clotting factor, the General Accounting Office maintains in a report released Feb. 12. The culprit is familiar: Payment for blood clotting factor — a biological used by hemophiliacs to prevent uncontrolled internal bleeding — is based on the now-notorious “average wholesale price,” a manufacturer-set price some critics have maintained is little more than a fiction. While Medicare pays 95 percent of AWP for clotting factor, the costs for providers is much lower, according to “Medicare: Payment for Blood Clotting Factor Exceeds Providers&rsquo...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.